229 related articles for article (PubMed ID: 8030156)
1. Platelet transfusions in 75 patients undergoing autologous bone marrow transplantation.
Lund BV; Madsen M
Transplant Proc; 1994 Jun; 26(3):1825. PubMed ID: 8030156
[No Abstract] [Full Text] [Related]
2. Platelet transfusion refractoriness due to graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation.
Taaning E; Jacobsen N
Transplant Proc; 1994 Jun; 26(3):1826. PubMed ID: 8030157
[No Abstract] [Full Text] [Related]
3. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
Pereira J; Bronfman L; BertÃn P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
[TBL] [Abstract][Full Text] [Related]
4. [Thrombomatch--an ELISA test for detection of antibodies to HLA antigens and platelet-specific antigens. Clinical experiences in compatibility testing of platelet transfusions].
Barz D; Gatzka E; Kollmorgen I
Beitr Infusionsther Transfusionsmed; 1996; 33():47-54. PubMed ID: 8974708
[TBL] [Abstract][Full Text] [Related]
5. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
Toor AA; Choo SY; Little JA
Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
[TBL] [Abstract][Full Text] [Related]
6. Supportive haemotherapy in bone marrow transplantation.
Mayr WR
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):455-8. PubMed ID: 2480289
[TBL] [Abstract][Full Text] [Related]
7. Platelet transfusion refractoriness attributable to HLA antibodies produced by donor-derived cells after allogeneic bone marrow transplantation from one HLA-antigen-mismatched mother.
Hatakeyama N; Hori T; Yamamoto M; Inazawa N; Iesato K; Miyazaki T; Ikeda H; Tsutsumi H; Suzuki N
Pediatr Transplant; 2011 Dec; 15(8):E177-82. PubMed ID: 20880381
[TBL] [Abstract][Full Text] [Related]
8. [Experiences in thrombocyte substitution following bone marrow transplantation].
Luboldt W; Henneberg-Quester KB; Schaefer UW; Beelen D; Mahmoud HK; Schmidt CG
Beitr Infusionther Klin Ernahr; 1986; 15():165-71. PubMed ID: 3530241
[No Abstract] [Full Text] [Related]
9. Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study.
Novotny VM; van Doorn R; Witvliet MD; Claas FH; Brand A
Blood; 1995 Apr; 85(7):1736-41. PubMed ID: 7703481
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
11. [Blood component transfusion in bone marrow transplant patients].
Harada M; Matsue K; Misawa T; Aoyagi N; Nakao S; Ueda M; Kondo K; Odaka K; Ohtake S; Teshima H
Rinsho Ketsueki; 1983 Sep; 24(9):1277-84. PubMed ID: 6363749
[No Abstract] [Full Text] [Related]
12. [Antibody formation after filtered blood cell replacement in hematologic-oncologic patients].
Barz D; Staack D; Lehmann R; Stange K; Schnurstein K
Beitr Infusionsther Transfusionsmed; 1996; 33():30-4. PubMed ID: 8974705
[TBL] [Abstract][Full Text] [Related]
13. [Innsbruck results of bone marrow transplantation in treatment of hematologic neoplasms and solid tumors].
Nachbaur D; Schwaighofer H; Thaler J; Weyrer W; Fink M; Nussbaumer W; Fritsch E; Niederwieser D
Wien Klin Wochenschr; 1994; 106(7):201-7. PubMed ID: 8197754
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow purging with etoposide/methylprednisolone in patients undergoing autologous bone marrow transplantation.
Pineiro L; Fay J; Collins R; Herzig G
Prog Clin Biol Res; 1994; 389():17-21. PubMed ID: 7700899
[No Abstract] [Full Text] [Related]
15. [Bone marrow transplantation in aplastic anemia with refractory states in platelet transfusions].
Kodoh H; Horiuchi N; Nakada H; Kumakawa J; Shirafuji N
Rinsho Ketsueki; 1986 Jul; 27(7):1278-81. PubMed ID: 3537368
[No Abstract] [Full Text] [Related]
16. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients.
Lo SC; Chang JS; Lin SW; Lin DT
Transfusion; 2005 May; 45(5):761-5. PubMed ID: 15847666
[TBL] [Abstract][Full Text] [Related]
17. Human histocompatibility antigens (HLA).
Kumar R; Mittal KK
Indian Pediatr; 1983 Oct; 20(10):763-70. PubMed ID: 6373600
[No Abstract] [Full Text] [Related]
18. [Demonstration of platelet-specific alloantibodies in HLA-sensitized hematologic oncologic patients].
Schnaidt M; Wernet D; Mayer G; Northoff H
Beitr Infusionsther Transfusionsmed; 1994; 32():240-3. PubMed ID: 9480099
[TBL] [Abstract][Full Text] [Related]
19. Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors.
Vox Sang; 2003 Jan; 84(1):73-88. PubMed ID: 12542737
[No Abstract] [Full Text] [Related]
20. Platelet refractoriness due to combined anti-HLA and anti-HPA-5a alloantibodies: clinical management during myeloablative allogeneic HSCT and development of a quantitative MAIPA assay.
Arber C; Bertrand G; Halter J; Boehlen F; Kaplan C; Gratwohl A
Br J Haematol; 2007 Oct; 139(1):159-61. PubMed ID: 17854320
[No Abstract] [Full Text] [Related]
[Next] [New Search]
